glp-1 pdb Glucagon-like peptide-1 receptor Prolonged Activation of the GLP-1

For instance, in November 2024, according to the World Health Organization November 2024 (WHO), over 95% of people globally are affected by diabetes, with type 2 diabetesonce considered an adult-onset, non-insulin-dependent conditionbecoming more common among children due to changing eating habits

Long-term efficacy, safety & duration: While GLP-1s have shown impressive short-term results, the long-term picture remains blurry

For more context, see our guide to prebiotics, probiotics, and synbiotics

Additionally, the endorsement of these therapies by leading medical organizations further solidifies their position in the treatment landscape, thereby driving growth in the market